PlainPharmaWatch

CMS Open Payments · Tool

Avid Radiopharmaceuticals, Inc. vs Avanos Medical

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Avid Radiopharmaceuticals, Inc. has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 1,793, versus 298 for the other company. Its single largest recorded recipient represents 29.1% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Avid Radiopharmaceuticals, Inc.
HHI 1,793 · top recipient 29.1%
Ranked #789 of 1,838 companies by HHI
Avanos Medical
HHI 298 · top recipient 6.9%
Ranked #1,462 of 1,838 companies by HHI

Payment Overview

Total Payments
$1.1M
% of Industry
0.0%
Transactions
51
Avg per Transaction
$21.9K
Recipients
38
Avg per Recipient
$29.4K
Payment Types
2
Top Payment Type
Travel and Lodging
Company B

Avanos Medical

Total Payments
$1.1M
% of Industry
0.0%
Transactions
3,887
Avg per Transaction
$290.37
Recipients
3,846
Avg per Recipient
$293.47
Payment Types
5
Top Payment Type
Honoraria

Highlighted values indicate the higher figure for each metric.

Total payments compared

Avid Radiopharmaceuticals, Inc. vs Avanos Medical - total reported payments in CMS Open Payments PY2024

Avanos Medical$1.1MAvid Radiopharmaceuticals,…$1.1M

General Payment Types Breakdown

Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.

Avid Radiopharmaceuticals, Inc.

Travel and Lodging $6.4K

79.6%

Food and Beverage $1.6K

20.4%

Avanos Medical

Honoraria $643.1K

74.2%

Food and Beverage $138.5K

16.0%

Travel and Lodging $85.1K

9.8%

Consulting Fee $455.57

0.1%

Gift $23.56

0.0%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Avid Radiopharmaceuticals, Inc.

  1. 1

    KEVIN PATRICK WEBER

    $2,341.31 · 4 txns

  2. 2

    JOSEPH WILLIAM SAM

    $1,370.21 · 4 txns

  3. 3

    MARIA ROSANA PONISIO

    $1,301.10 · 3 txns

  4. 4

    GIUSEPPE ESPOSITO

    $1,248.70 · 3 txns

  5. 5

    ERNEST GORDON DEPUEY III

    $981.38 · 4 txns

Avanos Medical

  1. 1

    FELIX GONZALEZ

    $59,404.98 · 41 txns

  2. 2

    RAJIV TEWARI

    $51,297.97 · 52 txns

  3. 3

    MAXIM ECKMANN

    $46,898.23 · 40 txns

  4. 4

    ALAA ABD-ELSAYED

    $43,371.44 · 26 txns

  5. 5

    SANDEEP AMIN

    $42,302.61 · 37 txns

Summary Comparison

Metric Avid Radiopharmaceuticals, Inc. Avanos Medical
Total Payments $1.1M $1.1M
% of Industry Total 0.0% 0.0%
Transaction Count 51 3,887
Avg per Transaction $21.9K $290.37
Recipient Count 38 3,846
Avg per Recipient $29.4K $293.47
Payment Type Count 2 5
Top Payment Type Travel and Lodging Honoraria

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.